Simulations Plus Inc
NASDAQ:SLP
Simulations Plus Inc
NASDAQ:SLP
Price:
50.74 USD
2.59%
Market Closed
Updated:
May 15, 2024
Simulations Plus Inc
Research & Development
|
Simulations Plus Inc
Research & Development Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Simulations Plus Inc
NASDAQ:SLP
|
Research & Development
-$4.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$119.8m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$80.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Research & Development
-$135.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is Simulations Plus Inc's Research & Development?
Research & Development
-4.6m
USD
-4.6m
USD
Based on the financial report for Feb 29, 2024, Simulations Plus Inc's Research & Development amounts to -4.6m USD.
What is Simulations Plus Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-18%
-18%
Over the last year, the Research & Development growth was -16%. The average annual Research & Development growth rates for Simulations Plus Inc have been -6% over the past three years , -16% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
